Literature DB >> 16699532

Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.

U R Deotare, A Vishwabandya, V Mathews, B George, A Srivastava, M Chandy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16699532     DOI： 10.1038/sj.bmt.1705378

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

1.  Pulsed-high-dose dexamethasone as a treatment for pure red cell aplasia following ABO-incompatible allogeneic stem cell transplantation.

Authors:  X Yang; M Levis
Journal:  Transfus Med       Date:  2014-08       Impact factor: 2.019

2.  Oral High Dose Dexamethasone for Pure Red Cell Aplasia Following ABO-Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report.

Authors:  Sanjeev Kumar Sharma; Suman Kumar; Narendra Agrawal; Pravas Mishra; Tulika Seth; Manoranjan Mahapatra
Journal:  Indian J Hematol Blood Transfus       Date:  2013-06-09       Impact factor: 0.900

Review 3.  Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.

Authors:  Javier Marco-Ayala; Inés Gómez-Seguí; Guillermo Sanz; Pilar Solves
Journal:  Bone Marrow Transplant       Date:  2020-11-14       Impact factor: 5.483

4.  Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.

Authors:  Georg Stussi; Jörg Halter; Eveline Bucheli; Piero V Valli; Lutz Seebach; Jürg Gmür; Alois Gratwohl; Urs Schanz; Jakob R Passweg; Jörg D Seebach
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

5.  Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sung-Hoon Jung; Jae-Sook Ahn; Deok-Hwan Yang; Hyung Chul Park; Soo-Young Bae; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Case Rep Oncol       Date:  2012-02-29

6.  Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Ammon Handisurya; Nina Worel; Werner Rabitsch; Marija Bojic; Sahra Pajenda; Roman Reindl-Schwaighofer; Wolfgang Winnicki; Andreas Vychytil; Hanna A Knaus; Rainer Oberbauer; Kurt Derfler; Philipp Wohlfarth
Journal:  Front Med (Lausanne)       Date:  2020-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.